RetiSpec
Toronto
About RetiSpec
RetiSpec is developing a non-invasive eye scanner for early detection of Alzheimer’s Disease pathology years before symptoms occur, so that clinicians can intervene with emerging therapeutics early, when there’s a chance of actually impacting the disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $10.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2024)
- Website: retispec.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/retispec-49441 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.